Biotech

All Articles

OS Therapies refiles $6M IPO to fund HER2 medicine, preclinical ADCs

.Operating system Therapies will definitely provide on the NYSE American inventory exchange this mor...

ALX's fizzling CD47 response cost sends out stock spiraling down

.ALX Oncology's period 2 gastric cancer cells reaction price has actually diminished. After seeing i...

Ionis centers eye ailment coming from aim ats of Roche-partnered prospect after data dissatisfy

.One More of Ionis Pharmaceuticals' key midphase readouts has fallen short of expectations, urging t...

Biogen's CEO said no unsafe sell 2023. He's ready to be vibrant

.While Biogen's pharma peers are hunting for late-stage possessions along with little bit of risk, C...

Instil refills pipeline in $2B biobucks take care of ImmunOnco

.Instil Biography has actually been a biotech searching for a pipe after it ditched its lead resourc...

Biogen bows out Denali Alzheimer's collab

.Biogen has actually restored rights to a very early Alzheimer's condition plan to Denali Therapeuti...

Takeda water faucets brand-new head people oncology company-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our summary of substantial leadership hirings, shootings and...

Vertex, beaten through AATD once more, drops 2 possessions on throw away heap

.Tip's effort to address a rare hereditary disease has hit another obstacle. The biotech tossed pair...

Vir gains 3 T-cell engagers from Sanofi, lays off 25% of team

.Vir Medical's second-quarter incomes file had not been short of significant updates. The business i...

Galapagos stops CAR-T tissue treatment trial over Parkinsonism case

.Galapagos has stopped enrollment in a trial of a BCMA-directed CAR-T cell therapy, pushing the brak...